Boston Scientific (BSX) PT Raised to $29 at Needham & Company Following 4Q Report
Tweet Send to a Friend
Needham & Company raised its price target on Boston Scientific (NYSE: BSX) to $29.00 (from $28.00) while maintaining a Buy ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
